Rx-TO-OTC SWITCHES WOULD BE DISCOURAGED BY FDA USER FEES, P-A's O'KEEFE TELLS HOUSE BUDGET HEARING; IBA NOTES DETERRENT EFFECT ON SMALL BUSINESS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".